Command Palette

Search for a command to run...

Clinical Trials · NCT02794402

Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI

CompletedPhase 2Exenatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Uppsala University
Enrollment
44
Start date
Sep 2015
Locations
2 sites, Austria, Sweden
Primary endpoint
BMI SDS (Body Mass Index Standard Deviation Score)
View Exenatide compound reference